--- title: "ABL Bio-Technologies Ltd (526955) — Share Price, Financials & Analysis" symbol: "526955" company: "ABL Bio-Technologies Ltd" canonical: "https://tapetide.com/stocks/526955" isin: "INE707D01016" bse_code: "526955" sector: "Healthcare" industry: "Pharmaceuticals & Biotechnology" generated_at: "2026-09-13T18:59:39.189Z" --- # ABL Bio-Technologies Ltd (526955) Canonical page: https://tapetide.com/stocks/526955 ## Company - **BSE Code:** 526955 - **ISIN:** INE707D01016 - **Sector:** Healthcare - **Industry:** Pharmaceuticals & Biotechnology - **Macro Sector:** Healthcare - **Stock Type:** EQUITY - **Listed Since:** 2006-03-01 - **Face Value:** ₹10 - **F&O Eligible:** No - **Website:** ablbiotechnologies.com ## About ABL Bio Technologies Limited is an India-based company. The company is engaged in bio technology industry. ## Latest Price ## Key Insights ### Strengths - Stock is trading at 0.04 times its book value ### Weaknesses - Company has low interest coverage ratio. - Company has a low return on equity of -31.8% over last 3 years. - Contingent liabilities of Rs.4.52 Cr. - Company might be capitalizing the interest cost ## Growth Rates | Metric | 1Y | 3Y | | --- | --- | --- | | net income growth | 20% | 22% | | revenue growth | -100% | — | ## Financial Statements ### Quarterly Results All figures in ₹ crore unless the row name says otherwise. | Item | Dec 2013 | Mar 2014 | Jun 2014 | Sep 2014 | Dec 2014 | Mar 2015 | Jun 2015 | Sep 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sep 2016 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Expenses | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0 | 0.02 | 0 | 0 | 0 | | Operating Profit | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | -0.02 | -0.01 | 0 | -0.02 | 0 | 0 | 0 | | Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Depreciation | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.03 | 0.03 | 0.03 | | Profit before tax | -0.03 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 | -0.04 | -0.03 | -0.03 | -0.03 | | Tax % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | Net Profit | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | -0.03 | -0.03 | -0.03 | -0.03 | -0.03 | | EPS in Rs | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | -0.05 | -0.04 | -0.04 | -0.04 | -0.04 | -0.04 | ### Profit & Loss All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | TTM | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | Sales | 7 | 9.27 | 16.86 | 8.15 | 2.22 | 0.04 | 0 | 0 | | Expenses | 5.76 | 7.54 | 13.63 | 7.76 | 22.22 | 0.57 | 0.12 | 0.02 | | Operating Profit | 1.24 | 1.73 | 3.23 | 0.39 | -20 | -0.53 | -0.12 | -0.02 | | OPM % | 17.71 | 18.66 | 19.16 | 4.79 | -900.9 | -1325 | — | — | | Other Income | 1.01 | 1.56 | 0.1 | 0 | 0 | 0 | 0.01 | 0 | | Interest | 0.28 | 0.62 | 1.16 | 1.12 | 0.52 | 0 | 0 | 0 | | Depreciation | 0.16 | 0.21 | 0.22 | 0.23 | 0.12 | 0.07 | 0.07 | 0.11 | | Profit before tax | 1.81 | 2.46 | 1.95 | -0.96 | -20.64 | -0.6 | -0.18 | -0.13 | | Tax % | 7.18 | 12.6 | 9.74 | 1.04 | 0 | 0 | 0 | — | | Net Profit | 1.68 | 2.15 | 1.76 | -0.97 | -20.64 | -0.6 | -0.18 | -0.12 | | EPS in Rs | — | — | — | -1.18 | -25.17 | -0.73 | -0.22 | -0.16 | | Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 0 | 0 | — | ### Balance Sheet All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | | --- | --- | --- | --- | --- | --- | --- | --- | | Equity Capital | 4.1 | 4.1 | 4.1 | 8.2 | 8.2 | 8.2 | 8.2 | | Reserves | 0.94 | 6.76 | 8.52 | 32.01 | 11.13 | 10.54 | 10.36 | | Borrowings | 5.17 | 10.13 | 14.14 | 16.59 | 16.66 | 16.96 | 17.1 | | Other Liabilities | 4.33 | 6.4 | 7.84 | 8.88 | 9.6 | 9.53 | 9.43 | | Total Liabilities | 14.54 | 27.39 | 34.6 | 65.68 | 45.59 | 45.23 | 45.09 | | Fixed Assets | 2.67 | 7.38 | 7.59 | 7.42 | 35.1 | 34.86 | 34.79 | | CWIP | 0 | 5.92 | 7.34 | 7.62 | 0 | 0 | 0 | | Investments | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.3 | 1.31 | | Other Assets | 10.57 | 12.79 | 18.37 | 49.34 | 9.19 | 9.07 | 8.99 | | Total Assets | 14.54 | 27.39 | 34.6 | 65.68 | 45.59 | 45.23 | 45.09 | ### Cash Flow All figures in ₹ crore unless the row name says otherwise. | Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | | --- | --- | --- | --- | --- | --- | --- | --- | | Cash from Operating Activity | -3.33 | 1.79 | -1.64 | 0.77 | -9.56 | -0.47 | -0.11 | | Cash from Investing Activity | -0.05 | -5.28 | -1.9 | -0.89 | -19.88 | 0.17 | -0.02 | | Cash from Financing Activity | 3.38 | 5.99 | 1.21 | 29.97 | -0.45 | 0.36 | 0.13 | | Net Cash Flow | 0 | 2.5 | -2.33 | 29.85 | -29.89 | 0.06 | 0 | | Free Cash Flow | -3.38 | -3.49 | -3.54 | -0.12 | -38.25 | -0.3 | -0.12 | | CFO/OP | -265 | 103 | -51 | 197 | 48 | 89 | 92 | ### Ratios | Item | Mar 2006 | Mar 2007 | Mar 2008 | Mar 2009 | Mar 2010 | Mar 2011 | Mar 2012 | | --- | --- | --- | --- | --- | --- | --- | --- | | Debtor Days | 159.56 | 120.88 | 163.45 | 320.66 | 44.39 | 2920 | — | | Inventory Days | 187.68 | 198.51 | 113.16 | 252.04 | 6.53 | 0 | — | | Days Payable | 477.84 | 353.79 | 277.75 | 706.4 | 827.08 | — | — | | Cash Conversion Cycle | -130.6 | -34.41 | -1.14 | -133.69 | -776.16 | 2920 | — | | Working Capital Days | 255.5 | 141.75 | 214.54 | 424.12 | -159.48 | -8942.5 | — | | ROCE % | — | 19.81 | 13.24 | 0.41 | -43.37 | -1.67 | -0.5 | ## Shareholding Pattern ### annual | Category | Jun 2016 | | --- | --- | | Promoters | 0.6% | | FIIs | 6.35% | | DIIs | 4.54% | | Public | 88.51% | | No. of Shareholders | 3957 | ### Quarterly | Category | Jun 2016 | | --- | --- | | Promoters | 0.6% | | FIIs | 6.35% | | DIIs | 4.54% | | Public | 88.51% | | No. of Shareholders | 3957 | ## Technical Indicators Derived from daily closing prices and recomputed each trading session; values move with the market. - **Overall Signal:** Sell - **Buy / Neutral / Sell:** 5 / 6 / 8 ### Moving Averages — summary: **Strong Sell** | Indicator | Value | Signal | | --- | --- | --- | | SMA (10) | 89.49 | Sell | | EMA (10) | 88.38 | Sell | | SMA (20) | 86.68 | Sell | | EMA (20) | 86.93 | Sell | | SMA (50) | 81.98 | Buy | | EMA (50) | 83.82 | Buy | | SMA (100) | 80.6 | Buy | | EMA (100) | 84.12 | Buy | | SMA (200) | 89.07 | Sell | | EMA (200) | 86.37 | Sell | ### Oscillators — summary: **Sell** | Indicator | Value | Signal | | --- | --- | --- | | RSI (14) | 49.73 | Neutral | | MACD (12,26,9) | 2.15 | Sell | | Stochastic (14,3,3) | 44.38 | Neutral | | ADX (14) | 23.76 | Neutral | | Williams %R (14) | -79.99 | Neutral | | ATR (14) | 4.82 | High Volatility | | ROC (12) | -2.46 | Sell | | Stoch RSI (14) | 0 | Buy | | UO (7,14,28) | 34.77 | Neutral | ## Filings & Documents ### Other Documents | Date | Document | | --- | --- | | 9 Feb - Time Medical India launched CDSCO‑certified MICA and QUIN 1.5T MRI platforms at IRIA 2026, helium-free and zero boil-off. | [Announcement under Regulation 30 (LODR)-Press Release / Media Release 9 Feb - Time Medical India launched CDSCO‑certified MICA and QUIN 1.5T MRI platforms at IRIA 2026, helium-free and zero boil-off.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/62898e51-8674-4041-b578-9b2399b33b6c.pdf) | | 30 Jan - Company Secretary Aravindkumar V resigns effective close of business 10 February 2026, seeking new opportunities. (KMP) , Documents enclosed as Annexure-1 and resignation letter dated … | [Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 30 Jan - Company Secretary Aravindkumar V resigns effective close of business 10 February 2026, seeking new opportunities. (KMP) , Documents enclosed as Annexure-1 and resignation letter dated …](https://www.bseindia.com/xml-data/corpfiling/AttachHis/372e57e1-76c7-4925-9f09-4d779a6b1858.pdf) | | 3 Mar - FMV Global Innovations (wholly-owned) acquired 75% of PT Fischer Pariko Medical Ventures, Indonesia (incorporated 14-10-2024). | [Announcement Under Reg 30 3 Mar - FMV Global Innovations (wholly-owned) acquired 75% of PT Fischer Pariko Medical Ventures, Indonesia (incorporated 14-10-2024).](https://www.bseindia.com/xml-data/corpfiling/AttachHis/78be2ec9-08d8-492a-aeec-46e6f38530b4.pdf) | | 12 Feb - Monitoring agency: no deviation; Rs.358.46 crore preferential issue; Rs.270.40 crore raised as of Dec 31, 2025. | [Announcement under Regulation 30 (LODR)-Monitoring Agency Report 12 Feb - Monitoring agency: no deviation; Rs.358.46 crore preferential issue; Rs.270.40 crore raised as of Dec 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dd0df078-1c20-441c-8deb-a70945412a6d.pdf) | | — | [Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011. 6 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/EB9680C1_7291_459B_9A67_51D7FE9A0445_144129.pdf) | | — | [Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011. 6 Feb](https://www.bseindia.com/xml-data/corpfiling/AttachHis/7B91AE82_72BA_4684_986D_64F074E2A4F7_144744.pdf) | | — | [Standalone Financial Results, Limited Review Report for September 30, 2016 14 Nov 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=37D00649_C672_4BDD_961C_0684DDEA7BAE_085112.pdf) | | — | [Standalone Financial Results, Limited Review Report for September 30, 2016 14 Nov 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/11/37D00649_C672_4BDD_961C_0684DDEA7BAE_085112.pdf) | | — | [Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016 22 Oct 2016](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=545F82DD_B8BE_4220_AD1E_33456326AC00_105148.pdf) | | — | [Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016 22 Oct 2016](https://www.bseindia.com/xml-data/corpfiling/CorpAttachment/2016/10/545F82DD_B8BE_4220_AD1E_33456326AC00_105148.pdf) | ### Earnings Call Documents | Date | Document | | --- | --- | | Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8c9b2b68-dc14-42b8-92eb-51042b4e0397.pdf) | | Dec 2024 | [Concall - Dec 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/688bd4f9-24c8-4d8d-a121-089da90ff39d.pdf) | ### Annual Reports | Date | Document | | --- | --- | | from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/42e13537-07e8-4260-9aa6-bdad9e7b9da7.pdf) | | from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/9ebf875b-3edb-4d11-91b5-b9be7a45b591.pdf) | | from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/950076ae-2ad5-4fbb-982a-4f45351fcbcd.pdf) | | from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/524743/76349524743.pdf) | | from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/524743/71784524743.pdf) | | from bse | [Financial Year 2020 from bse](https://www.bseindia.com/bseplus/AnnualReport/524743/67635524743.pdf) | | from bse | [Financial Year 2019 from bse](https://www.bseindia.com/bseplus/AnnualReport/524743/5247430319.pdf) | | from bse | [Financial Year 2018 from bse](https://www.bseindia.com/bseplus/AnnualReport/524743/5247430318.pdf) | | from bse | [Financial Year 2017 from bse](https://www.bseindia.com/bseplus/AnnualReport/524743/5247430317.pdf) | | from bse | [Financial Year 2016 from bse](https://www.bseindia.com/bseplus/AnnualReport/524743/5247430316.pdf) | --- Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:59:39.189Z.